Skip to content

13F-HR filed by Aisling Capital Management LP

Aisling Capital Management LP filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-13, with 13 holding rows worth $191,825,000.

Accession
0001766721-19-000007
Filed
2019-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 13 entries on the cover page, a total value of $191,825,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $191,825,000 with VALUE read as thousands by filing date, 13F file number 028-19070. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BRIDGEBIO PHARMA INC10806X102COM3,835,722$82,353,000thousands by filing date
EIDOS THERAPEUTICS INC.28249H104Common Stock1,123,630$40,417,000thousands by filing date
TECTONIC THERAPEUTIC INC COM05455M100Stock893,079$12,610,000thousands by filing date
ObsEva SAH5861P103COM1,386,338$11,548,000thousands by filing date
MARKER THERAPEUTICS INC57055L107COM2,000,000$10,220,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM1,291,151$9,929,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM10,100,000$7,272,000thousands by filing date
ATRECA INC04965G109COM387,653$4,745,000thousands by filing date
NABRIVA THERAPEUTICS PLCG63637105SHS1,910,287$3,821,000thousands by filing date
ZOSANO PHARMA CORP98979H202COM NEW2,028,571$3,165,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM333,333$3,033,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS443,596$2,027,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock634,455$685,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001766721-19-000007this filing2019-11-13acceptance time not in the bulk data set